Warpaint London PLC PDMR Dealings and Total Voting Rights

RNS Number : 9563E

Warpaint London PLC

20 September 2024

 

20 September 2024

 

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

PDMR Dealings and Total Voting Rights

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces that on 19 September 2024, Matthew Goldstein, Managing Director of Retra and a PDMR, exercised 110,000 options over ordinary shares in the Company ("Shares") at an exercise price of 122 pence.  Mr Goldstein then sold the resultant 110,000 Shares from the exercise of options on the same day at a price of 543 pence per Share.

The above options were granted to Mr Goldstein on 24 May 2021 pursuant to the Company's Share Incentive Scheme and the resultant Shares are covered by the Company's Blocklisting which was announced by the Company on 3 October 2023.

The Company does not hold any Ordinary Shares in treasury.  Therefore, the total number of voting rights in the Company is 77,742,723 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Matthew Goldstein
2	Reason for the notification
a)	Position/status	Managing Director Retra, PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Warpaint London PLC
b)	LEI	213800EBJ2CN6KIDCO78
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 25p each     GB00BYMF3676
b)	Nature of the transaction	Exercise of share options and sale of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £1.22 (exercise) 110,000 £5.43 (sale) 110,000
d)	Aggregated information - Aggregated volume - Price	N/A   N/A
e)	Date of the transaction	19 September 2024
f)	Place of the transaction	Outside a trading venue and AIM, London Stock Exchange

 

 

Enquiries:

Warpaint London Sam Bazini - Chief Executive Officer Eoin Macleod - Managing Director Neil Rodol - Chief Financial Officer	c/o IFC
Shore Capital (Nominated Adviser & Broker) Patrick Castle, Daniel Bush - Corporate Advisory Fiona Conroy - Corporate Broking	020 7408 4090
IFC Advisory (Financial PR & IR) Tim Metcalfe, Graham Herring, Florence Chandler	020 3934 6630

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets.  In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

TVRBIGDCLSBDGSC